rs115475262
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_018100.4(EFHC1):c.1820A>G(p.Asn607Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000258 in 1,614,166 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. N607N) has been classified as Benign.
Frequency
Consequence
NM_018100.4 missense
Scores
Clinical Significance
Conservation
Publications
- juvenile myoclonic epilepsyInheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- epilepsyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| EFHC1 | NM_018100.4 | c.1820A>G | p.Asn607Ser | missense_variant | Exon 10 of 11 | ENST00000371068.11 | NP_060570.2 | |
| EFHC1 | NM_001172420.2 | c.1763A>G | p.Asn588Ser | missense_variant | Exon 11 of 12 | NP_001165891.1 | ||
| EFHC1 | NR_033327.2 | n.3146A>G | non_coding_transcript_exon_variant | Exon 9 of 10 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| EFHC1 | ENST00000371068.11 | c.1820A>G | p.Asn607Ser | missense_variant | Exon 10 of 11 | 1 | NM_018100.4 | ENSP00000360107.4 |
Frequencies
GnomAD3 genomes AF: 0.00135 AC: 206AN: 152232Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000350 AC: 88AN: 251136 AF XY: 0.000243 show subpopulations
GnomAD4 exome AF: 0.000144 AC: 210AN: 1461816Hom.: 1 Cov.: 32 AF XY: 0.000118 AC XY: 86AN XY: 727216 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00135 AC: 206AN: 152350Hom.: 0 Cov.: 32 AF XY: 0.00132 AC XY: 98AN XY: 74496 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:2
The c.1820A>G (p.N607S) alteration is located in exon 10 (coding exon 10) of the EFHC1 gene. This alteration results from a A to G substitution at nucleotide position 1820, causing the asparagine (N) at amino acid position 607 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Absence seizure;C1850778:Myoclonic epilepsy, juvenile, susceptibility to, 1 Benign:1
EFHC1-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
not provided Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at